Navigation Links
Kinerase Wins Allure Best of Beauty Award for 2nd Consecutive Year
Date:9/27/2011

NEW YORK, Sept. 27, 2011 /PRNewswire/ -- Kinerase, an icon of scientific skincare development, continues to provide award winning beauty for the second year in a row.  The Kinerase Restructure Firming Eye Cream has been named a winner in the 2011 Allure Best of Beauty Awards, appearing in the magazine's October 2011 issue.

(Photo:  http://photos.prnewswire.com/prnh/20110927/NY75304 )

This year, over 236 beauty products were chosen as winners across a number of categories, including skincare, hair care, cosmetics and tools. Winners were selected by Allure's editors and other industry leaders, trying thousands of products before awarding the top honors. The winning products -- which will boast the coveted Allure Best of Beauty seal of approval -- were honored by Allure at an awards ceremony Thursday night (9.15.11) at New York's Jazz at Lincoln Center.

KINERASE RESTRUCTURE FIRMING EYE CREAM:

A departure from the typical firming products, Kinerase Restructure Firming Eye Cream ($59 available at Ulta, Ulta.com, Nordstrom or Kinerase.com) visibly transforms skin by targeting elastin protein coils to lift and tone the contours of the eye area.

This luxurious Kinerase eye firming regimen combines the plant extract LOXL Stimulator, potent, clinically proven antioxidants and .15% Kinetin to improve skin elasticity and tone, tighten, and restructure for a more lifted look.  Restructure Firming Eye Cream also reduces the appearance of expression wrinkles and deeply moisturizes for firmer, smoother, more youthful-looking skin.  

About Kinerase

KINERASE® skincare provides powerful anti-aging efficacy, delivering clinically-proven visible results in gentle skin-caring formulations. The power behind Kinerase is Kinetin (N6-furfuryladenine), a plant-based antioxidant whose anti-aging properties were discovered when scientists found that it prevented plant leaves from drying out and withering. With Kinerase, indulge the luxury of skincare science to reveal youthful, radiant skin.  For more information visit http://www.kinerase.com or https://www.facebook.com/#!/Kinerase

About Valeant Pharmaceuticals International, Inc.

Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of neurology, dermatology and branded generics.  More information about Valeant Pharmaceuticals International, Inc. can be found at www.valeant.com.


'/>"/>
SOURCE Kinerase
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Kinerase® Introduces "Change Your Skin, Change Your Life" Charity Campaign
2. Pelleve(TM) Wrinkle Treatment System Featured On Beauty Spaces TV Show
3. FDA: Potentially Harmful Stimulant Found in Slimming Beauty Capsules
4. CVS/pharmacy Launches ExtraCare Beauty Club
5. TRIA Beauty Leading the Charge in Bridging Gap Between Science and Skin Health
6. Baxter Awarded Pandemic Advanced Supply Contract from the Department of Health
7. Federal Funding Awarded to Test Antimicrobial Properties of Copper Metals
8. Niaid / Barda Awards Elusys a $12 Million Contract to Further Develop Anthim, the Companys Anthrax Therapeutic
9. Isis Announces $1.2 Million Award to Its Ibis Subsidiary to Expand Influenza Detection Capabilities and Enable Large-Scale Influenza Transmission Studies
10. NIST Awards $2 Million to Velcura Therapeutics, Inc. for Innovative Technology R&D - Dual-Action Therapies for Bone Disease
11. Virogenomics, Inc. Awarded $2 Million National Institute of Standards and Technology (NIST) Advanced Technology Program Grant to Develop Integrated Diagnostic Biosensors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... June 26, 2016 One of Australia,s ... the formation of a new biotechnology company, Noxopharm Limited [ABN 50 ... an IPO and to list on the ASX. Noxopharm ... ready to enter a Phase 1 clinical study later this year. ... address one of the biggest problems facing cancer patients - the ...
(Date:6/26/2016)... , June 27, 2016 Jazz Pharmaceuticals ... waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of ... acquisition of Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: ... p.m. (Eastern Daylight Time). As previously announced ... into a definitive merger agreement under which Jazz Pharmaceuticals ...
(Date:6/26/2016)... -- VMS Rehab Systems, Inc. ( www.vmsrehabsystemsinc.com ) reported today ... to build a strong and stable market for trading ... the OTC Markets-pink current trading platform. Explains ... seeing an anomaly in market trading activities that may ... Company, but shareholders and market players as well. I ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... 27, 2016 , ... The OSHA Training Center at ... Center headquartered in Northern California, has issued an important reminder to employers to ... Employers with workers exposed to high temperatures should establish a complete heat ...
(Date:6/27/2016)... ... June 27, 2016 , ... "FCPX editors can now reveal ... Final Cut Pro X," said Christina Austin - CEO of Pixel Film Studios. ... Cut Pro X users can now reveal the media of their split screens ...
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... ... for mental health professionals, announced today its affiliation with Tennessee Counseling Association. ... solutions to the network of the Tennessee Counseling Association, adding exclusive benefits and ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... today announced its strategic partnership with Connance, a healthcare industry leader providing ... companies’ proven, proprietary technology combine to provide health systems, hospitals and ambulatory ...
(Date:6/27/2016)... ... June 27, 2016 , ... A revolution is underway. ... ambulance transport experience for the millions of people who require these medical transport ... taxi industry through the use of technology. Now, SmartEMS has put forth an ...
Breaking Medicine News(10 mins):